用於治療癌症的OX40激動劑和4-1BB激動劑單克隆抗體的組合
- 专利权人:
- PFIZER INC.
- 发明人:
- LONG, Hua,THALL, Aron David
- 申请号：
- HK19101614
- 公开号：
- HK1259253A1
- 申请日:
- 2019.01.30
- 申请国别(地区):
- HK
- 年份:
- 2019
- 代理人:
- 摘要：
- The present disclosure describes combination therapies comprising an agonist of OX40 and an agonist of 4-1BB, and the use of the combination therapies for the treatment of cancer.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- Expansion of Tumor Infiltrating Lymphocytes (TIL) with Tumor Necrosis Factor Receptor Superfamily (TNFRSF) Agonists and Treatment Combinations of TILs and TNFRSF Agonists
- COMBINATION OF MONOCLONAL ANTIBODIES OX40 AGONIST AND 4-1BB AGONIST FOR TREATMENT OF CANCER
- ANTICORPS HUMANISÉS ANTI-OX40 ET UTILISATIONS DESDITS ANTICORPS
- HUMANIZED ANTI-OX40 ANTIBODIES AND USES THEREOF
- טיפול משולב הכולל אגוניסטים קושרי ox40 ואנטגוניסטים קושרי ציר pd–1
